Staphylococcus aureus vaccine - Antigenics
Latest Information Update: 24 Oct 2021
At a glance
- Originator Antigenics
- Class Bacterial vaccines; Conjugate vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 25 Sep 2006 Discontinued - Preclinical for Staphylococcal infections in USA (unspecified route)
- 27 Aug 2001 Aquila Biopharmaceuticals has been integrated into Antigenics
- 01 Dec 2000 Aquila Biopharmaceuticals has been acquired by Antigenics